Código 46 Competitors and Similar CompaniesClear all
Editas Medicine's competitors and similar companies include Amyris.
 Editas Medicine Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics. |  Amyris Amyris is a biotechnology company that develops chemical ingredients using microbial fermentation. | |
Founding Date | Founding Date 2013 | Founding Date 2003 |
Type | Type Public | Type Private |
Tags | ||
Locations | Locations Cambridge, US HQ Boulder, US Cambridge, US | Locations Emeryville, US HQ Sao Paulo, BR |
Employees | Employees 20816% increase | Employees 1,0031% decrease |
Financial | ||
Revenue (est.) | Revenue (est.) $40.5m (FY, 2025) | Revenue (est.) $269.8m (FY, 2022) |
Net income | Net income ($160.1m) (FY, 2025) | Net income ($543.4m) (FY, 2022) |
Funding | ||
Total funding raised | Total funding raised $ 210m | Total funding raised $ 551.9m |
For sources of this data, please see the company profile
View Company Profiles
Amyris
HQ
Emeryville, US
Employees
1,003↓ 1% decrease
Amyris is a biotechnology company that develops chemical ingredients using microbial fermentation.
View company